Welcome to the 3-Part Webinar Series centered around the entire genetics and genomics landscape in Breast Cancer, covering patients at high risk, those who are newly diagnosed, undergoing treatment, or in survivorship. This series will equip you with the expertise to seamlessly integrate genetic and genomic testing into your clinical practice.
In Part One, we will delve into the Foundations and Applications of Germline Testing. Join us as we engage with experts in the field, including Jennifer Lazzara, DNP, ARNP, CGRA, who leads a Breast Cancer Genetics Clinic at Cancer Care Northwest, and Laura Brzeskiewicz, CGC, and Medical Science Liaison Manager at Myriad Genetics.
In Part 2 of our 3-Part series exploring the comprehensive genetics and genomics landscape in breast cancer, we’ll dive into Risk Assessment and High-Risk Management. Come along as we explore strategies and tests to assess breast cancer risk and tools for implementing a high-risk breast program in your practice. Let’s identify patients together who are at high risk for breast cancer so we can #BeatBreastCancer.
Join Eric Manahan, MD, MBA, FACS, a leading expert in general and breast surgery, as he shares insights on trending topics in genetic testing for breast cancer. In this webinar, Dr. Manahan covers the importance and underutilization of genetic testing in breast cancer, disparities in genetic testing, unlocking the potential of tumor genomics, exciting research opportunities, and much more. Don’t miss out — register today to secure your spot and gain valuable insights on how to elevate your approach to patient care.
Register for Wednesday, May 22nd at 12:00 PM ET